Saudi Re logo
Saudi Reinsurance Co. (Saudi Re) announced its financial results for the first half of the current year 2022 with improved operating results by 8% compared to the previous year registering SAR 24 million
The company recorded gross written premiums (GWPs) of SAR 920 million compared with SAR 955 million in the similar period of the previous year. This was propelled by a staggering growth in the second quarter with a rate of 166% recording a GWP of SAR 321 million.
The systemic volatility caused by increase interest rates and foreign currency fluctuations, affected the bottom line and resulted in a decline in net profit before zakat by 62% recording SAR 14 million for the first half of 2022.
Commenting on the first half results, Saudi Re MD & CEO, Fahad Al-Hesni noted that Saudi Re has maintained a well-balanced underwriting portfolio with 52% international business, while keeping focus on risk selection which reflected positively on the underwriting performance.
He further highlighted the strong growth of Saudi Re’s recent product, the inherent defects insurance (IDI), and recorded GWP of SAR 223 million which indicates positive prospects for growth given that Saudi Re holds the privilege to exclusively reinsure the mandatory IDI program.
The Kingdom’s sole reinsurer received the Central Bank’s approval to increase capital to SAR 1.336 billion through right issue offering for the purpose of strengthening the company’s capital base and supporting future expansion initiatives domestically and internationally as part of its Strategy Toward 2026.
Furthermore, Saudi Re maintained a strong financial position with a A3 financial strength rating by Moody’s. Total equity increased by end of first half to SAR 968 million compared with SAR 957 in the previous year, while technical reserves were further strengthened to reach SAR 1.6 billion and total assets exceeded SAR 3.7 billion by end if the first half.
Saudi Re operates in more than 40 countries across the Middle East, Asia, Africa and Lloyd’s market in the UK, and specializes in life and non-life treaty and facultative reinsurance solutions.
Comments
{{DisplayName}}
{{ElapsedTime}}